Background: Hypotension and bradycardia are the common side effects of spinal anesthesia. Strategies for treating spinal anesthesia-induced hypotension include intravenous volume administration or pharmacological reverse of systemic vascular resistance reduction, by using vasopressor agents. However, rapid infusion of large amounts of fluid is not appropriate, and sometimes may be hazardous in patients with cardiac dysfunction. We investigated efficacy of intravenous atropine usage for prevention of spinal anesthesia-induced hypotension.Materials & Methods: In a randomized, double blind clinical trial, 42 ASA I patients, aged between 20-50 yrs, undergoing elective lower abdominal surgery, were studied in two groups. The patients were received either placebo (group P, n = 21) or atropine 10 µg/kg (group A, n=21) after induction of spinal anesthesia. All patients received IV infusion of 7 ml/kg balance salt solution (Ringer) and midazolam 0.02 mg/kg before induction of spinal anesthesia. Heart rate, systolic and diastolic blood pressure were measured before and during the first 30 mins after induction of anesthesia. Results: Hemodynamic changes, in placebo group were significantly more than atropine group (p<0.03). Conclusion: In patients without present contraindication, administration of atropine is beneficial for prevention of hypotension following spinal anesthesia.